Literature DB >> 22798249

Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus.

Wen-Jin Fu1, Yao-Gao Fang, Ren-Tang Deng, Shu Wen, Mei-Lian Chen, Zhi-Hong Huang, Hui-Hua Tang, Shi-Long Xiong, Xian-Zhang Huang, Qian Wang.   

Abstract

The aim of this study was to assess the relationship between urinary Smad1 and glomerular hyperfiltration (GHF) in type 2 diabetes mellitus (T2DM), and to explore the factors related to the urinary Smad1 in T2DM. The reference value of the estimated glomerular filtration rate (eGFR) was determined in 248 healthy individuals. 30 patients with GHF, 58 patients with norm-GFR T2DM, and 24 healthy patients who served as controls were recruited. Urinary Smad1, fasting plasma glucose (FPG), fasting serum C-Peptide (C-P), hemoglobin A1C (HbA1c), cystatin C, and other chemistry laboratory parameters of T2DM participants and controls were measured. Patients with GHF had higher levels of urinary Smad1 than the control group, and those with norm-GFR. For T2DM patients with body mass index, age, and gender adjustments, urinary Smad1 was positively correlated with FPG, HbA1C, and eGFR, but negatively correlated with fasting serum C-P. Multivariate linear regression analysis demonstrated that eGFR, HbA1C, and fasting serum C-P were independently associated with urinary Smad1. High levels of urinary Smad1 were found in GHF patients with T2DM, which may be another potential mechanism of GHF in relation to diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798249     DOI: 10.1007/s12020-012-9741-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  29 in total

1.  Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction.

Authors:  G Gruden; S Thomas; D Burt; S Lane; G Chusney; S Sacks; G Viberti
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis.

Authors:  Hongxia Jia; Lili Yu; Bin Gao; Qiuhe Ji
Journal:  Endocrine       Date:  2011-07-02       Impact factor: 3.633

3.  Glomerular hyperfiltration in microalbuminuric NIDDM patients.

Authors:  P Vedel; J Obel; F S Nielsen; L E Bang; T L Svendsen; O B Pedersen; H H Parving
Journal:  Diabetologia       Date:  1996-12       Impact factor: 10.122

Review 4.  Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker.

Authors:  Hideharu Abe; Takeshi Matsubara; Hidenori Arai; Toshio Doi
Journal:  Histol Histopathol       Date:  2011-04       Impact factor: 2.303

5.  Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients.

Authors:  S P Silveiro; R Friedman; M J de Azevedo; L H Canani; J L Gross
Journal:  Diabetes Care       Date:  1996-02       Impact factor: 19.112

6.  Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.

Authors:  S W Hong; M Isono; S Chen; M C Iglesias-De La Cruz; D C Han; F N Ziyadeh
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

7.  Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study.

Authors:  M Krolewski; P W Eggers; J H Warram
Journal:  Kidney Int       Date:  1996-12       Impact factor: 10.612

Review 8.  Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.

Authors:  M P O'Donnell; B L Kasiske; W F Keane
Journal:  FASEB J       Date:  1988-05       Impact factor: 5.191

9.  Hemodynamically mediated glomerular injury and the progressive nature of kidney disease.

Authors:  B M Brenner
Journal:  Kidney Int       Date:  1983-04       Impact factor: 10.612

10.  Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes.

Authors:  Linda H Ficociello; Bruce A Perkins; Bijan Roshan; Janice M Weinberg; Ann Aschengrau; James H Warram; Andrzej S Krolewski
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

View more
  3 in total

Review 1.  New insights into molecular mechanisms of diabetic kidney disease.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  Am J Kidney Dis       Date:  2014-02       Impact factor: 8.860

2.  Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.

Authors:  Qiao Li; Lie Feng; Jiaying Li; Qianqian Chen
Journal:  Endocrine       Date:  2013-08-13       Impact factor: 3.633

3.  Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy.

Authors:  Kaifeng Guo; Junxi Lu; Jingxin Kou; Mian Wu; Lei Zhang; Haoyong Yu; Mingliang Zhang; Yuqian Bao; Haibing Chen; Weiping Jia
Journal:  BMC Nephrol       Date:  2015-10-08       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.